Date closed: 1/3/2018
Value: C$115 million
On January 3, 2018, Aphria Inc. (Aphria or the Company) (TSX: APH or USOTCQB: APHQF) closed its short form prospectus offering, on a bought deal basis, including the exercise in full of the underwriters' over-allotment option. A total of 8,363,651 common shares (the Shares) of the Company were sold at a price of $13.75 per Share, for aggregate gross proceeds of $115,000,201. The offering was underwritten by a syndicate of underwriters led by Clarus Securities Inc. and included AltaCorp Capital Inc., Cormark Securities Inc. and Canaccord Genuity Corp.
Aphria, headquartered in Leamington, Ontario, is engaged in the business of producing and selling medical cannabis.